Safety and efficacy of atezolizumab in understudied populations with pretreated urinary tract carcinoma: subgroup analyses of the SAUL study in real-world practice
Axel S. Merseburger, Daniel Castellano, Thomas Powles, Yohann Loriot, Margitta Retz, Jens Voortman, Robert A. Huddart, Craig Gedye, Michiel S. Van Der Heijden, Howard Gurney, Michael Ong, Sabine de Ducla, Julie Pavlova, Simon Fear, Cora N. Sternberg
Research output: Contribution to journal › Article › peer-review
9
Link opens in a new tab
Citations
(Scopus)